Despierta

What Despierta does

Despierta is a Miami-based venture studio and fund founded in 2021 by Christian Seale, Christopher Lee, and Justin Dangel. It builds, co-founds, and invests in healthcare companies across three thematic verticals: value-based care (primary care platforms and at-risk specialty care entities), science-backed consumer health (products derived from academic research with global consumer potential), and "future of health" (tech-enabled services supporting the transition from sick-care to well-care). The studio's active portfolio includes Rise Health (rebranded as Primor Health), a technology-enabled primary care platform operating in Nevada, New Mexico, and Texas; Fourier Health, an AI-powered clinical intake platform integrating with EHR systems; Mangrove Health, a Florida-based value-based primary care organization serving Medicare, Medicaid, and Marketplace populations; Akita Biosciences, a consumer health company developing the Profi Nasal Spray using PCANS technology; and Subquadratic, a generative AI company with 12M-token context windows. Despierta previously invested in companies including Babyscripts, Voiceitt, Atlas, Quick'rCare, Wellth, Carevoyance, Circulation, Ready, Samesky Health, Higi, Algorex Health, Hyka, Fertilidad Integral, b.well, Care Angel, Roundtrip, and Cybexys. The studio offers co-founders competitive salary, equity, and benefits, and provides functional expertise across healthcare, regulatory, design, engineering, financing, human capital, and IT. Despierta generates returns through equity ownership in co-founded companies, with prior exits including the acquisition of InfiniteMD by ConsumerMedical and subsequently by Alight Solutions (NYSE:ALIT). The firm is headquartered in Miami, FL with a secondary office in Boston, MA, and operates with 11-50 employees.

Name

Despierta

Legal name

Despierta

Website

https://despierta.vc

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

11–50 employees

Short description

Despierta is a Miami-based venture studio that co-founds and invests in healthcare companies across value-based care, science-backed consumer health, and health tech-enabled services, bundling capital with operational and clinical expertise.

Ownership category

akta.pro rank

Headquarters

HQ city

Miami

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Venture Capital Returns: Despierta generates returns through equity ownership in portfolio companies they co-found and invest in. The studio model involves taking equity stakes in early-stage healthcare companies and realizing returns through exits via acquisitions or public offerings.
2. Studio Co-Founding Services: Co-found companies with entrepreneurs, providing immediate team support, functional expertise, and capital. Co-founders receive competitive salary, equity, and benefits package.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

Despierta is a Miami-based venture studio and fund that co-founds healthcare companies with entrepreneurs, providing capital, an in-house operating team, and access to clinical and customer networks in exchange for equity. Its portfolio focuses on three pillars: value-based primary and specialty care, science-backed consumer health, and "future of health" tech-enabled services. Beyond the studio build service, Despierta also deploys capital into earlier healthcare investments through its affiliated fund activity.

Product overview

Despierta is a Miami-based venture studio and holding company that builds and invests in healthcare companies across value-based care, science-backed consumer health, and health tech services. The portfolio includes four studio builds: Rise Health (now Primor Health) as a technology-enabled primary care platform for value-based care; Fourier Health as an AI-powered clinical intake automation tool that integrates with EHR systems; Mangrove Health as a value-based primary care organization serving Florida populations; and Akita Biosciences as a consumer health company with nasal spray technology. Additionally, Despierta has made previous investments in companies including Babyscripts, Voiceitt, Atlas, Quick'rCare, and others across the healthcare technology spectrum.

Differentiator

Problem solved

Functional benefit

Products and services

• Venture Studio Co-Founding Services Service offering through which Despierta co-builds healthcare companies alongside chosen entrepreneurs, contributing capital and an in-house team across healthcare, regulatory, design, engineering, financing, human capital, and IT. Intended for healthcare founders, physicians, scientists, and operators looking to convert ideas into standalone companies within value-based care, science-backed consumer health, and "future of health" tech-enabled services.
• Rise Health (now Primor Health) Provider-focused, technology-enabled, global-risk primary care platform and organization that leverages technology to operate and support value-based primary care clinics, providing primary care practices with access to premium care delivery models and top-tier specialists to reduce practitioner administrative burden.
• Fourier Health AI-powered platform that automates clinical intake by integrating with electronic health record systems to organize disjointed patient data and produce concise summaries for clinicians. Delivers a 98% reduction in document validation and saves two to three hours of administrative time per patient. Targeted at clinicians and health systems.
• Mangrove Health Value-based primary care organization focused on improving access and outcomes for seniors and families across Florida. Transforms primary care delivery through coordinated, team-based care enhanced by technology and AI. Targeted at Medicare, Medicaid, and Marketplace populations in Florida.
• Akita Biosciences Consumer health company developing innovative nasal spray formulations for drug, device, and cosmetic applications. Its Profi Nasal Spray uses PCANS (pathogen capture and neutralizing spray) technology to create an eight-hour barrier that captures airborne germs and neutralizes them before entry. Targeted at consumers seeking drug-free respiratory protection.
• Subquadratic Generative AI model company developing a novel architecture with 12M-token context windows, designed to address throughput and bottleneck constraints in large language models. Targeted at AI developers and enterprise teams requiring long-context reasoning.

Quantifiable outcome

• 40+ active healthcare companies launched from network with $200M+ raised in financing
• +2 more outcomes

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability2 records

Partnerships

Five partnerships are on record, tiered flagship and supporting.

• Mangrove HealthflagshipStrategic or Co-development Partner · 23 April 2026Mangrove Health was co-founded by Elena Castañeda and Dr. Emily Maxson as a value-based primary care organization focused on Medicare, Medicaid, and Marketplace populations in Florida. Despierta and Mako provided strategic investment for clinical center expansion.
• Fourier HealthflagshipStrategic or Co-development Partner · 1 October 2023Fourier Health was co-founded by James Lloyd and Christopher Lee as a startup automating medical records summarization using AI. Despierta provided pre-seed backing and ongoing support, with the company raising $8.4M in external seed funding.
• Rise Health (now Primor Health)flagshipStrategic or Co-development Partner · 19 December 2022Rise Health was co-founded by Despierta partners Justin Dangel, Keith Pinter, and Mike Phillips as a primary care platform leveraging technology to support value-based care. It has since rebranded as Primor Health and expanded to Nevada, New Mexico, and Texas.
• Akita BiosciencesflagshipStrategic or Co-development Partner · 1 June 2022Akita Biosciences was co-founded by Jeff Karp, Nitin Joshi, and Alex Revelos to develop a revolutionary drug-free nasal spray (Profi) using PCANS technology to improve respiratory health. Christopher Lee serves as co-founder.
• ConsumerMedical (acquired by Alight Solutions)supportingStrategic or Co-development Partner · 1 January 2013InfiniteMD, co-founded by Christopher Lee, was acquired by ConsumerMedical in 2020, and subsequently by Alight Solutions (NYSE:ALIT) with 30M lives under management across Fortune 500 companies. This represents a successful exit from the Despierta ecosystem.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Andreessen Horowitz (a16z Bio): Large venture firm with dedicated bio/health fund actively investing across value-based care, digital health, and biotech. Comparable in healthcare thesis but operates as a traditional fund rather than a studio.
• General Catalyst: Established venture firm with explicit Health Assurance thesis covering value-based care, digital health, and healthcare delivery. Comparable on healthcare investment focus though much larger and broader in stage range.
• Optum Ventures: Corporate venture arm of UnitedHealth/Optum investing heavily in value-based care, primary care platforms, and healthcare AI. Highly comparable thematic alignment with Despierta's portfolio.
• Oak HC/FT: Specialized venture firm focused exclusively on healthcare services and fintech. Comparable in healthcare-only thesis and value-based care investing approach.

Direct peers

• StartUp Health: Health-focused startup studio and investor that supports founders building transformative health companies. Comparable operating model focused on healthcare venture creation.
• Redesign Health: Healthcare-focused venture studio that co-founds and builds companies with entrepreneurs. Most direct comparable given the studio model, healthcare vertical focus, and co-founder support approach Despierta employs.
• Flare Capital Partners: Healthcare technology-focused VC partnering with entrepreneurs building innovative health companies. Comparable thesis around health tech and value-based care, though structured as a traditional fund.
• Town Hall Ventures: Healthcare-focused VC investing in companies serving Medicaid and Medicare populations with value-based care models. Strong thematic overlap with Despierta's primary care portfolio focus.

Emerging players

• Maveron: Consumer-focused VC with healthcare experience that backs mission-driven founders. Comparable in early-stage healthcare investing; co-founder Christian Seale previously worked at Maveron.
• WELL Health Ventures: Digital health investor and operator backing healthcare technology companies. Comparable in digital health investment focus and value-based care enablement.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/despierta

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Despierta